NCT01439295

Brief Summary

Urinary ascorbyl peroxide level in the first week of life will be a good predictor of Bronchopulmonary dysplasia (BPD) in preterm infants less than 33 weeks of gestation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

September 16, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 23, 2011

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

November 18, 2015

Status Verified

November 1, 2015

Enrollment Period

5.3 years

First QC Date

September 16, 2011

Last Update Submit

November 17, 2015

Conditions

Keywords

Ascorbyl peroxideBronchopulmonary dysplasiaRedox statusNecrotising entercolitisRetinopathy of prematurityPatent ductus arteriosusIntraventricular hemorrhagePeriventricular leucomalacia

Outcome Measures

Primary Outcomes (1)

  • Bronchopulmonary Dysplasia

    To correlate the level of urinary Ascorbyl peroxide and BPD. Full diagnosis and classification (to mild, moderate or severe) is at 36 weeks of corrected age; so even for most premature infants (like 23 weeks of gestation) there will be a need for follow up for less than 4 month to have the final diagnosis at 36 weeks

    4 Months

Secondary Outcomes (2)

  • The redox status (in blood)

    First week of life (week 1) and 36 semaines CA

  • Major neonatal outcomes (NEC, ROP, PDA, IVH, PVL)

    4 Months

Study Arms (1)

Preterm less than 33 weeks

This cohort will be composed of premature infants born before 33 weeks of gestational age, admitted to the neonatal intensive care unit at Sainte-Justine hospital and receiving parenteral nutrition (PN) during their first week of life.

Eligibility Criteria

Age23 Weeks - 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Preterm infants less than 33 weeks of getation

You may qualify if:

  • Preterm infants less than 33 weeks of gestation\<
  • Admission to CHU Sainte-JUstien neonatal intensive care unit
  • Receiving Parenteral nutrition during the first week of life
  • Parental consent

You may not qualify if:

  • Major congenital anomalies
  • Sever perinatal asphyxia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Montreal, Sainte-Justine Hospital

Montreal, Quebec, H3T1C5, Canada

Location

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Urine sample (650 µl) Blood sample (500 µl)

MeSH Terms

Conditions

Bronchopulmonary DysplasiaRetinopathy of PrematurityDuctus Arteriosus, PatentLeukomalacia, Periventricular

Condition Hierarchy (Ancestors)

Ventilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesRetinal DiseasesEye DiseasesHeart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEncephalomalaciaVascular Diseases

Study Officials

  • Ibrahim Mohamed, Mb CHB

    University of Montreal, Sainte Justine Hospital

    PRINCIPAL INVESTIGATOR
  • Jean-claude Lavoie, PhD

    University of Montreal, Sainte-Justine hospital research center

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct professor of peditarics, division of neonatology

Study Record Dates

First Submitted

September 16, 2011

First Posted

September 23, 2011

Study Start

August 1, 2010

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

November 18, 2015

Record last verified: 2015-11

Locations